Literature DB >> 12546318

Causes of death and poor survival prognostic factors in thai patients with systemic sclerosis.

Sutat Ruangjutipopan1, Nuntana Kasitanon, Worawit Louthrenoo, Waraporn Sukitawut, Ramjai Wichainun.   

Abstract

Causes of death and poor prognostic factors for patients with systemic sclerosis (SSc) were studied in 222 cases. Their mean age at the onset and duration of disease was 48.9 +/- 12.0 years and 23.3 +/- 29.3 months, respectively. Fifty-three per cent were diffuse subtype. Patients with diffuse SSc had more digital pitting scars and more muscle, heart, lung, and esophageal involvement than those with limited subtypes (p < or = 0.02). One hundred and six patients were lost to follow-up. With a median follow-up duration of 25 months, 31 of the remaining 116 patients (26.7%) died. SSc related death occurred in 18 cases, in which the lung, heart and kidney (renal crisis) were the major causes. Infection contributed to the remaining 13 deaths. When compared with living patients, using a univariate analysis, factors associated with a reduced survival rate were age of > 45 years at the onset, diffuse skin thickness, and lung, gastrointestinal tract, heart, kidney and muscle involvement (p < or = 0.001). In the multivariate analysis, only age of > 45 years at onset and cardiac involvement remained poor prognostic factors (p = 0.04 and 0.001, respectively).

Entities:  

Mesh:

Year:  2002        PMID: 12546318

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  13 in total

Review 1.  Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review.

Authors:  Matthew E Falagas; Katerina G Manta; Gregoria I Betsi; Georgios Pappas
Journal:  Clin Rheumatol       Date:  2006-12-21       Impact factor: 2.980

2.  Comparison of the clinical phenotype of systemic sclerosis patients in Iran and France in two university centers.

Authors:  Yannick Allanore; Farhad Gharibdoost; Ahmad Reza Jamshidi; Ali Javinani; Jérôme Avouac; Elnaz Rastkar; Sadid Hooshmandi; Hoda Kavosi
Journal:  J Scleroderma Relat Disord       Date:  2018-11-20

3.  The prognostic factors of systemic sclerosis for survival among Koreans.

Authors:  Jinhyun Kim; Sue Kyung Park; Ki Won Moon; Eun Young Lee; Yun Jong Lee; Yeong Wook Song; Eun Bong Lee
Journal:  Clin Rheumatol       Date:  2009-12-03       Impact factor: 2.980

4.  Survival and causes of death in systemic sclerosis patients: a single center registry report from Iran.

Authors:  Hadi Poormoghim; Elham Andalib; Arash Jalali; Afshin Ghaderi; Ali Ghorbannia; Nazanin Mojtabavi
Journal:  Rheumatol Int       Date:  2016-04-09       Impact factor: 2.631

Review 5.  An insight into rheumatology in Thailand.

Authors:  Worawit Louthrenoo
Journal:  Nat Rev Rheumatol       Date:  2014-09-09       Impact factor: 20.543

6.  Causes of death, survival and risk factors of mortality in Thai patients with early systemic sclerosis: inception cohort study.

Authors:  Suparaporn Wangkaew; Narawudt Prasertwitayakij; Arintaya Phrommintikul; Saowanee Puntana; Juntima Euathrongchit
Journal:  Rheumatol Int       Date:  2017-10-12       Impact factor: 2.631

7.  Juvenile onset systemic sclerosis: a single center experience of 23 cases from Asia.

Authors:  Ramnath Misra; Gurmeet Singh; Parshant Aggarwal; Amita Aggarwal
Journal:  Clin Rheumatol       Date:  2006-12-19       Impact factor: 3.650

8.  Lack of CTGF*-945C/G Dimorphism in Thai Patients with Systemic Sclerosis.

Authors:  Worawit Louthrenoo; Nuntana Kasitanon; Ramjai Wichainun; Suparaporn Wangkaew; Waraporn Sukitawut; Yuka Ohnogi; Shoji Kuwata; Fujio Takeuchi
Journal:  Open Rheumatol J       Date:  2011-10-19

9.  Serious infections in people with systemic sclerosis: a national US study.

Authors:  Jasvinder A Singh; John D Cleveland
Journal:  Arthritis Res Ther       Date:  2020-06-29       Impact factor: 5.156

Review 10.  Gastrointestinal Involvement in Systemic Sclerosis: An Update.

Authors:  John B Miller; Nisarg Gandhi; John Clarke; Zsuzsanna McMahan
Journal:  J Clin Rheumatol       Date:  2018-09       Impact factor: 3.517

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.